Boston Trust Walden Corp Boosts Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Boston Trust Walden Corp raised its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,253,815 shares of the medical device company’s stock after buying an additional 19,038 shares during the period. Cooper Companies comprises approximately 1.0% of Boston Trust Walden Corp’s investment portfolio, making the stock its 15th biggest position. Boston Trust Walden Corp owned 0.63% of Cooper Companies worth $138,346,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Benjamin F. Edwards & Company Inc. boosted its holdings in Cooper Companies by 248.6% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after acquiring an additional 174 shares during the period. Covestor Ltd grew its holdings in shares of Cooper Companies by 305.9% in the first quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares during the last quarter. Innealta Capital LLC purchased a new position in Cooper Companies in the 2nd quarter worth about $25,000. Crewe Advisors LLC lifted its holdings in Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after buying an additional 252 shares in the last quarter. Finally, Clearstead Trust LLC bought a new position in Cooper Companies in the 1st quarter worth about $36,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Up 0.5 %

NASDAQ:COO traded up $0.52 during mid-day trading on Friday, hitting $107.82. 3,270,373 shares of the company’s stock traded hands, compared to its average volume of 1,128,228. The company has a fifty day moving average of $105.73 and a 200 day moving average of $96.72. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38. The company has a market capitalization of $21.47 billion, a P/E ratio of 63.42, a P/E/G ratio of 2.56 and a beta of 0.98.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.05. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.84 earnings per share. On average, analysts forecast that The Cooper Companies, Inc. will post 3.65 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on COO shares. Robert W. Baird raised their price objective on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Piper Sandler increased their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a report on Thursday, August 29th. Morgan Stanley boosted their price target on shares of Cooper Companies from $95.00 to $104.00 and gave the company an “equal weight” rating in a report on Tuesday, September 10th. Finally, Jefferies Financial Group upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and increased their price objective for the company from $107.00 to $115.00 in a research note on Tuesday, July 16th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $115.00.

Insider Transactions at Cooper Companies

In other news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total value of $12,129,356.16. Following the transaction, the chief operating officer now directly owns 44,696 shares of the company’s stock, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Cooper Companies news, COO Daniel G. Mcbride sold 114,992 shares of Cooper Companies stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the sale, the chief operating officer now directly owns 44,696 shares in the company, valued at approximately $4,714,534.08. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Brian G. Andrews sold 24,788 shares of the stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the completion of the sale, the chief financial officer now owns 6,614 shares in the company, valued at $700,422.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 256,373 shares of company stock worth $27,637,427. Company insiders own 2.00% of the company’s stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.